# A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia

> **NCT03359785** · PHASE2 · COMPLETED · sponsor: **Neurocrine Biosciences** · enrollment: 31 (actual)

## Conditions studied

- Schizophrenia

## Interventions

- **DRUG:** Luvadaxistat
- **DRUG:** Matching Placebo

## Key facts

- **NCT ID:** NCT03359785
- **Lead sponsor:** Neurocrine Biosciences
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-01-10
- **Primary completion:** 2020-12-21
- **Final completion:** 2020-12-21
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-02-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03359785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03359785, "A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT03359785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*